Shenyang Xingqi Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Shenyang Xingqi Pharmaceutical Co Ltd cash flow reinvestment rate. Shenyang Xingqi Pharmaceutical Co Ltd (300573) has a Cash Flow Reinvestment Rate of 0.16x as of September 2025, reinvesting CN¥43.05 Million (capex CN¥43.05 Million ) from operating cash flow of CN¥268.97 Million. Explore how well can Shenyang Xingqi Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shenyang Xingqi Pharmaceutical Co Ltd (2011–2024)
Cash flow reinvestment rate of Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2024. Historical reinvestment intensity for Shenyang Xingqi Pharmaceutical Co Ltd across 14 annual periods. Explore 300573 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Shenyang Xingqi Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2011–2024)
Shenyang Xingqi Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2011 to 2024. Year-by-year capital reinvestment analysis for Shenyang Xingqi Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Shenyang Xingqi Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | CN¥208.71 Million | CN¥416.98 Million | CN¥198.71 Million | ▼ -69.7% |
| 2023 | 1.65x | CN¥523.90 Million | CN¥317.57 Million | CN¥261.96 Million | ▼ -21.1% |
| 2022 | 2.09x | CN¥598.38 Million | CN¥286.26 Million | CN¥299.23 Million | ▲ +184.8% |
| 2021 | 0.73x | CN¥225.29 Million | CN¥306.96 Million | CN¥95.06 Million | ▼ -62.4% |
| 2020 | 1.95x | CN¥238.39 Million | CN¥122.16 Million | CN¥108.15 Million | ▼ -27.8% |
| 2019 | 2.70x | CN¥200.21 Million | CN¥74.08 Million | CN¥69.98 Million | ▼ -32.2% |
| 2018 | 3.99x | CN¥175.53 Million | CN¥44.01 Million | CN¥45.29 Million | ▲ +314.2% |
| 2017 | 0.96x | CN¥31.48 Million | CN¥32.70 Million | CN¥29.29 Million | ▲ +285.7% |
| 2016 | 0.25x | CN¥7.02 Million | CN¥28.12 Million | CN¥3.62 Million | ▼ -33.8% |
| 2015 | 0.38x | CN¥8.09 Million | CN¥21.43 Million | CN¥4.69 Million | ▼ -94.0% |
| 2014 | 6.29x | CN¥81.79 Million | CN¥13.00 Million | CN¥81.79 Million | ▼ -60.3% |
| 2013 | 15.83x | CN¥132.98 Million | CN¥8.40 Million | CN¥132.98 Million | ▲ +543.5% |
| 2012 | 2.46x | CN¥103.25 Million | CN¥41.96 Million | CN¥103.25 Million | ▲ +43.6% |
| 2011 | 1.71x | CN¥42.06 Million | CN¥24.54 Million | CN¥42.06 Million | — |